SEC Form 4 · accession 0001144204-17-029344
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James G. Marken
Officer — SVP Ops & Prod Dev
Period of report
May 22, 2017
Accepted (ET)
May 24, 2017 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2017 | F | 278 | $47.01 | D | 51,549 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted stock and the stock options vests in equal annual installments on the first, second, third and fourth anniversaries of the grant date.